 |
The Journal of Neuroscience, August 17, 2005, 25(33):7615-7622; doi:10.1523/JNEUROSCI.1245-05.2005
Previous Article | Next Article 
Development/Plasticity/Repair
Regular Exercise Prolongs Survival in a Type 2 Spinal Muscular Atrophy Model Mouse
Clément Grondard,1
Olivier Biondi,1
Anne-Sophie Armand,1
Sylvie Lécolle,1
Bruno Della Gaspera,1
Claude Pariset,1
Hung Li,2
Claude-Louis Gallien,1
Pierre-Paul Vidal,1
Christophe Chanoine,1 and
Frédéric Charbonnier1
1Université Paris Descartes, Centre Universitaire des Saints-Pères, Laboratoire de Neurobiologie des Réseaux Sensorimoteurs, Unité Mixte de Recherche 7060, Centre National de la Recherche Scientifique, Equipe Biologie du Développement et de la Différenciation Neuromusculaire, F-75270 Paris, France, and 2Institute of Molecular Biology, Academia Sinica, Nankang, Taipei 115, Taiwan
Several studies indicate that physical exercise is likely to be neuroprotective, even in the case of neuromuscular disease. In the present work, we evaluated the efficiency of running-based training on type 2 spinal muscular atrophy (SMA)-like mice. The model used in this study is an SMN (survival motor neuron)-null mouse carrying one copy of a transgene of human SMN2. The running-induced benefits sustained the motor function and the life span of the type 2 SMA-like mice by 57.3%. We showed that the extent of neuronal death is reduced in the lumbar anterior horn of the spinal cord of running-trained mice in comparison with untrained animals. Notably, exercise enhanced motoneuron survival. We showed that the running-mediated neuroprotection is related to a change of the alternative splicing pattern of exon 7 in the SMN2 gene, leading to increased amounts of exon 7-containing transcripts in the spinal cord of trained mice. In addition, analysis at the level of two muscles from the calf, the slow-twitch soleus and the fast-twitch plantaris, showed an overall conserved muscle phenotype in running-trained animals. These data provide the first evidence for the beneficial effect of exercise in SMA and might lead to important therapeutic developments for human SMA patients.
Key words: spinal muscular atrophy; exercise; mouse model; neuroprotection; alternative splicing; muscular phenotype
Received March 31, 2005;
revised June 6, 2005;
accepted July 2, 2005.
This article has been cited by other articles:

|
 |

|
 |
 
S. Corti, M. Nizzardo, M. Nardini, C. Donadoni, S. Salani, R. Del Bo, D. Papadimitriou, F. Locatelli, N. Mezzina, F. Gianni, et al.
Motoneuron Transplantation Rescues the Phenotype of SMARD1 (Spinal Muscular Atrophy with Respiratory Distress Type 1)
J. Neurosci.,
September 23, 2009;
29(38):
11761 - 11771.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. F. Rose Jr, V. B. Mattis, H. Rindt, and C. L. Lorson
Delivery of recombinant follistatin lessens disease severity in a mouse model of spinal muscular atrophy
Hum. Mol. Genet.,
March 15, 2009;
18(6):
997 - 1005.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Preisler, G. Andersen, F. Thogersen, C. Crone, T. D. Jeppesen, F. Wibrand, and J. Vissing
Effect of aerobic training in patients with spinal and bulbar muscular atrophy (Kennedy disease)
Neurology,
January 27, 2009;
72(4):
317 - 323.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Biondi, C. Grondard, S. Lecolle, S. Deforges, C. Pariset, P. Lopes, C. Cifuentes-Diaz, H. Li, B. della Gaspera, C. Chanoine, et al.
Exercise-Induced Activation of NMDA Receptor Promotes Motor Unit Development and Survival in a Type 2 Spinal Muscular Atrophy Model Mouse
J. Neurosci.,
January 23, 2008;
28(4):
953 - 962.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. J. Swoboda, J. T. Kissel, T. O. Crawford, M. B. Bromberg, G. Acsadi, G. D'Anjou, K. J. Krosschell, S. P. Reyna, M. K. Schroth, C. B. Scott, et al.
Perspectives on Clinical Trials in Spinal Muscular Atrophy
J Child Neurol,
August 1, 2007;
22(8):
957 - 966.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Corti, F. Locatelli, D. Papadimitriou, R. Del Bo, M. Nizzardo, M. Nardini, C. Donadoni, S. Salani, F. Fortunato, S. Strazzer, et al.
Neural stem cells LewisX + CXCR4 + modify disease progression in an amyotrophic lateral sclerosis model
Brain,
May 1, 2007;
130(5):
1289 - 1305.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|

|